KIN
Kindred Biosciences, Inc.
KIN
KIN
Delisted
KIN was delisted on the 27th of August, 2021.
72 hedge funds and large institutions have $177M invested in Kindred Biosciences, Inc. in 2019 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 30 increasing their positions, 12 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
72
Holders Change
-3
Holders Change %
-4%
% of All Funds
1.58%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
7
Increased
30
Reduced
12
Closed
10
Calls
$397K
Puts
–
Net Calls
+$397K
Net Calls Change
-$775K
Top Buyers
1 |
Ameriprise
Minneapolis,
Minnesota
|
$7.16M |
2 |
Allianz Asset Management
Munich,
Germany
|
$4.95M |
3 |
Vanguard Group
Malvern,
Pennsylvania
|
$12.9M |
4 |
DGHMC
Dalton, Greiner, Hartman, Maher & Co
New York
|
$971K |
5 |
Goldman Sachs
New York
|
$988K |